JPS54101436A - Medicine having activity as pgs controlling agent - Google Patents

Medicine having activity as pgs controlling agent

Info

Publication number
JPS54101436A
JPS54101436A JP16443078A JP16443078A JPS54101436A JP S54101436 A JPS54101436 A JP S54101436A JP 16443078 A JP16443078 A JP 16443078A JP 16443078 A JP16443078 A JP 16443078A JP S54101436 A JPS54101436 A JP S54101436A
Authority
JP
Japan
Prior art keywords
pgs
medicine
activity
controlling agent
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16443078A
Other languages
Japanese (ja)
Inventor
Hainritsuhi Pegeru Karuru
Uookaa Hansu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roecar Holdings NV
Original Assignee
Roecar Holdings NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roecar Holdings NV filed Critical Roecar Holdings NV
Publication of JPS54101436A publication Critical patent/JPS54101436A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005Glycosides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP16443078A 1977-12-31 1978-12-29 Medicine having activity as pgs controlling agent Pending JPS54101436A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772759171 DE2759171A1 (en) 1977-12-31 1977-12-31 MEDICINAL PRODUCTS WITH EFFECT AS PROSTAGLANDIN SYNTHETASE INHIBITOR

Publications (1)

Publication Number Publication Date
JPS54101436A true JPS54101436A (en) 1979-08-10

Family

ID=6027873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16443078A Pending JPS54101436A (en) 1977-12-31 1978-12-29 Medicine having activity as pgs controlling agent

Country Status (19)

Country Link
JP (1) JPS54101436A (en)
AR (1) AR223334A1 (en)
AU (1) AU516933B2 (en)
BE (1) BE873222A (en)
CA (1) CA1113006A (en)
CH (1) CH637829A5 (en)
DE (1) DE2759171A1 (en)
DK (1) DK587778A (en)
ES (1) ES476443A1 (en)
FR (1) FR2425859A1 (en)
GB (1) GB2039217B (en)
IL (1) IL56345A (en)
IT (1) IT1109336B (en)
LU (1) LU80739A1 (en)
NL (1) NL7812656A (en)
NZ (1) NZ189297A (en)
PT (1) PT69012A (en)
SE (1) SE466683B (en)
ZA (1) ZA787399B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5536471A (en) * 1978-07-05 1980-03-14 Roecar Holdings Nv Spiroketaline compound
JPH02180830A (en) * 1988-11-15 1990-07-13 Kanoldt Arzneimittel Gmbh Hecogenin ester derivative-containing drug composition and use of said composition for curing of prostate hypertrophy

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5874619A (en) * 1981-10-29 1983-05-06 Nippon Shinyaku Co Ltd Liposome and its preparation
CA1209912A (en) 1982-04-19 1986-08-19 Siegfrid Drewes Extract of plants of the family of hypoxidaceae for treatment of cancer
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
DE3401178A1 (en) * 1984-01-14 1985-07-18 Roecar Holdings (Netherlands Antilles) N.V., Willemstad, Curacao, Niederländische Antillen USE OF PHYTOSTEROL GLYCOSIDES FOR TREATING INCREASED 5 (6) (ALPHA) EPOXICHOLESTEROL LEVELS
DE3416112A1 (en) * 1984-04-30 1985-10-31 Roecar Holdings (Netherlands Antilles) N.V., Willemstad, Curacao, Niederländische Antillen USE OF STEROLINES AND SPIROKETALINES AS LIPOXYGENAS REGULATORS
DE3829640C1 (en) * 1988-09-01 1990-04-26 Roecar Holdings (Netherlands Antilles) N.V., Willemstad, Curacao, Niederlaendische Antillen, Nl
DE3829641A1 (en) * 1988-09-01 1990-03-15 Roecar Holdings Nv TRANSDERMAL APPLICABLE PHARMACEUTICAL PREPARATIONS WITH STEROLINES AND / OR SPIROKETALINES
DE3829643A1 (en) * 1988-09-01 1990-03-15 Roecar Holdings Nv PHYTO AND ZOOSTEROLS AND THEIR DERIVATIVES WITH IMPROVED WATER SOLUBILITY
US5166194A (en) * 1988-09-01 1992-11-24 Roecar Holdings Transdermally applicable pharmaceutical preparations having a pharmaceutically usable glycoside content
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE35018B1 (en) * 1970-03-18 1975-10-15 Liebenberg R W Therapeutic agent
US3966918A (en) * 1973-12-12 1976-06-29 Nippon Shinyaku Co., Ltd. Method of preparing aqueous solutions of sterol glycosides and their ester derivatives
JPS51118817A (en) * 1975-04-08 1976-10-19 Nippon Shinyaku Co Ltd A process for preparing absorbable steroid glycoside pharmaceutical

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5536471A (en) * 1978-07-05 1980-03-14 Roecar Holdings Nv Spiroketaline compound
JPH02180830A (en) * 1988-11-15 1990-07-13 Kanoldt Arzneimittel Gmbh Hecogenin ester derivative-containing drug composition and use of said composition for curing of prostate hypertrophy

Also Published As

Publication number Publication date
AU4302478A (en) 1979-07-05
NL7812656A (en) 1979-07-03
IT7852493A0 (en) 1978-12-29
BE873222A (en) 1979-06-29
IL56345A (en) 1984-11-30
CA1113006A (en) 1981-11-24
ES476443A1 (en) 1979-10-16
AU516933B2 (en) 1981-07-02
DK587778A (en) 1979-07-01
IL56345A0 (en) 1979-03-12
GB2039217A (en) 1980-08-06
DE2759171A1 (en) 1979-07-12
ZA787399B (en) 1980-01-30
FR2425859A1 (en) 1979-12-14
NZ189297A (en) 1984-10-19
IT1109336B (en) 1985-12-16
FR2425859B1 (en) 1983-04-08
LU80739A1 (en) 1980-01-22
AR223334A1 (en) 1981-08-14
GB2039217B (en) 1982-08-04
SE466683B (en) 1992-03-23
DE2759171C2 (en) 1990-10-25
PT69012A (en) 1979-01-01
SE7813443L (en) 1979-07-01
CH637829A5 (en) 1983-08-31

Similar Documents

Publication Publication Date Title
GB2000136B (en) Therapeutic agents
GB2005248B (en) Therapeutic agents
ZA782816B (en) Therapeutic agents
GB2000138B (en) Therapeutic agents
JPS5418186A (en) Medical dressing
GB2000131B (en) Therapeutic agents
AU507028B2 (en) Therapeutic agents
JPS5289700A (en) Medical composition having antiiulcer activity
JPS54101436A (en) Medicine having activity as pgs controlling agent
AU516563B2 (en) Therapeutic treatment
JPS542341A (en) Medical composition
GB2004876B (en) Therapeutic agents
JPS5428829A (en) Antiithrombosis medical composition
GB2007656B (en) Therapeutic agents
ZA786184B (en) Therapeutic agents
ZA786259B (en) Therapeutic composition
ZA78554B (en) Novel therapeutic agents
JPS55105613A (en) Sweat controlling agent
GB2000510B (en) Therapeutic agents
GB2010824B (en) Therapeutic agents
JPS5463064A (en) Tumor control agent
JPS5470432A (en) Medical composition
JPS53101524A (en) Nonnmedical controlling agent for harmful organism
JPS542335A (en) Medical composition
JPS52118426A (en) Medical composition having selective histamineeh22acceptor stimulating activity